Factors associated with nonresponse to FMT identified in IBS

For patients with irritable bowel syndrome (IBS), those who are male and/or have low Alistipes levels are more likely to be nonresponders to fecal microbiota transplantation (FMT), according to a stud

Gastroenterology February 19,2024

Factors associated with nonresponse to FMT identified in IBS

For patients with irritable bowel syndrome (IBS), those who are male and/or have low Alistipes levels are more likely to be nonresponders to fecal microbiota transplantation (FMT), according to a stud

Gastroenterology February 19,2024

Does TikTok's chia-lemon 'internal shower' really beat constipation? Here's what science says

by Clare Collins,The ConversationCredit: AI-generated imageHeard about the chia seed-lemon juice "internal shower" drink? It's going viral on TikTok and is being hailed as a digest

Gastroenterology February 19,2024

Does TikTok's chia-lemon 'internal shower' really beat constipation? Here's what science says

by Clare Collins,The ConversationCredit: AI-generated imageHeard about the chia seed-lemon juice "internal shower" drink? It's going viral on TikTok and is being hailed as a digest

Gastroenterology February 19,2024

Alzheimer's breakthrough: Genetic link to gut disorders confirmed

by Edith Cowan UniversityClusters of significantly enriched biological pathways for AD and GERD.aKEGG: Kyoto Encyclopedia of Genes and Genomes pathways:intestinal immune network

Gastroenterology February 19,2024

Alzheimer's breakthrough: Genetic link to gut disorders confirmed

by Edith Cowan UniversityClusters of significantly enriched biological pathways for AD and GERD.aKEGG: Kyoto Encyclopedia of Genes and Genomes pathways:intestinal immune network

Gastroenterology February 19,2024

Upadacitinib superior to placebo in moderate-to-severe Crohn disease

by Elana GotkineFor patients with moderate-to-severe Crohn disease, upadacitinib induction and maintenance treatment are superior to placebo, according to a study published in the May 25 issue of the&

Gastroenterology February 19,2024

Upadacitinib superior to placebo in moderate-to-severe Crohn disease

by Elana GotkineFor patients with moderate-to-severe Crohn disease, upadacitinib induction and maintenance treatment are superior to placebo, according to a study published in the May 25 issue of the&

Gastroenterology February 19,2024

ChatGPT does not pass American College of Gastroenterology tests

by Elana GotkineThe natural language processing model Chat Generative Pretrained Transformer (ChatGPT) does not pass the American College of Gastroenterology (ACG) Self-Assessment Tests, according to

Gastroenterology February 19,2024

ChatGPT does not pass American College of Gastroenterology tests

by Elana GotkineThe natural language processing model Chat Generative Pretrained Transformer (ChatGPT) does not pass the American College of Gastroenterology (ACG) Self-Assessment Tests, according to

Gastroenterology February 19,2024

FDA approves first pill to treat moderate-to-severe Crohn's disease

by Cara MurezPatients with Crohn's disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib).Rinvoq is meant to treat adults

Gastroenterology February 19,2024

FDA approves first pill to treat moderate-to-severe Crohn's disease

by Cara MurezPatients with Crohn's disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib).Rinvoq is meant to treat adults

Gastroenterology February 19,2024

ACG issues guideline for management of upper GI bleeding

(HealthDay)—In an American College of Gastroenterology clinical guideline, published in the May issue of theAmerican Journal of Gastroenterology, recommendations are presented for the mana

Gastroenterology February 19,2024

ACG issues guideline for management of upper GI bleeding

(HealthDay)—In an American College of Gastroenterology clinical guideline, published in the May issue of theAmerican Journal of Gastroenterology, recommendations are presented for the mana

Gastroenterology February 19,2024

Cancer-targeting virus therapy combined with radiation more effective against brain cancer than either one alone

by Gillian Rutherford,University of AlbertaResearchers Mary Hitt (left) and Quinn Storozynsky found that using a cancer-targeting virus therapy at the same time as radiation gives more benefit t

Oncology February 19,2024

Cancer-targeting virus therapy combined with radiation more effective against brain cancer than either one alone

by Gillian Rutherford,University of AlbertaResearchers Mary Hitt (left) and Quinn Storozynsky found that using a cancer-targeting virus therapy at the same time as radiation gives more benefit t

Oncology February 19,2024

A cell surface marker for identifying tumor-initiating cells in pancreatic cancer

by Kumamoto UniversityROR1 is a cell surface receptor that promotes hyperproliferation, metastasis, and relapse in PDAC when highly expressed. Suppressing ROR1 reduces PDAC growth. Credit: Masaya

Oncology February 19,2024

A cell surface marker for identifying tumor-initiating cells in pancreatic cancer

by Kumamoto UniversityROR1 is a cell surface receptor that promotes hyperproliferation, metastasis, and relapse in PDAC when highly expressed. Suppressing ROR1 reduces PDAC growth. Credit: Masaya

Oncology February 19,2024

Endoscopy within six hours does not lower mortality in GI bleed

(HealthDay)—Endoscopy within six hours versus six to 24 hours after consultation is not associated with lower 30-day mortality in patients with acute upper gastrointestinal bleeding who are at high ri

Gastroenterology February 19,2024

Endoscopy within six hours does not lower mortality in GI bleed

(HealthDay)—Endoscopy within six hours versus six to 24 hours after consultation is not associated with lower 30-day mortality in patients with acute upper gastrointestinal bleeding who are at high ri

Gastroenterology February 19,2024